Adults 18 years and older may qualify for a study evaluating an investigational once-weekly study medication for weight management in individuals with obesity or overweight without type 2 diabetes.
Weight Management
Age Range:
18
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
Researchers are studying new medications that may help support weight loss and improve overall metabolic health.
This research study is evaluating an investigational study medication called RO7795068 (also known as CT-388). The purpose is to assess whether this medication can help reduce body weight and improve health outcomes in adults with obesity or overweight who do not have type 2 diabetes.
Participants will be randomly assigned to receive either RO7795068 or placebo. The study medication is given as a once-weekly injection, in addition to guidance on diet and physical activity.
Qualifications
You may be able to join if you:
- Are 18 years of age or older.
- Have obesity (BMI ≥30), or are overweight (BMI ≥27) with at least one weight-related health condition (such as high blood pressure, high cholesterol, or prediabetes).
- Have previously tried to lose weight through diet or exercise without long-term success.
- Do not have a diagnosis of type 1 or type 2 diabetes.
- Are not currently pregnant or breastfeeding.
FEATURED STUDIES
Post-Traumatic Stress Disorder (PTSD)
Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational
Bronchiectasis
Individuals with bronchiectasis who experience frequent flare-ups or ongoing respiratory symptoms may qualify for a research study evaluating a home
Hypertension & Type 2 Diabetes
Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for
Idiopathic Hypersomnia Study Interest List
Suburban Research Associates is conducting a clinical research study for adults with Idiopathic Hypersomnia for an upcoming study on daytime
Uncontrolled Hypertension
Adults 18–65 with a history of high blood pressure that remains elevated despite treatment may qualify for a study evaluating
Type 2 Diabetes
Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a